Vir Biotechnology, Inc. Board of Directors

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Mr. Brent Sabatini

Mr. Brent Sabatini

Senior VP, Principal Accounting Officer & Chief Accounting Officer

Mr. Jason O'Byrne

Mr. Jason O'Byrne

Executive VP & CFO

Dr. Jeff Calcagno M.D.

Dr. Jeff Calcagno M.D.

Executive VP & Chief Business Officer

Dr. Lawrence Corey M.D.

Dr. Lawrence Corey M.D.

Co-Founder & Scientific Advisor

Dr. Jennifer Eileen Towne Ph.D.

Dr. Jennifer Eileen Towne Ph.D.

Executive VP & Chief Scientific Officer

Dr. Ann M. Hanly Ph.D.

Dr. Ann M. Hanly Ph.D.

Executive VP & Chief Technology Officer

Ms. Vanina de Verneuil J.D.

Ms. Vanina de Verneuil J.D.

Executive VP, General Counsel & Corporate Secretary

Ms. Arran Attridge

Ms. Arran Attridge

Senior Vice President of Corporate Communications

Dr. Louis J. Picker M.D.

Dr. Louis J. Picker M.D.

Co-Founder & Scientific Advisor

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.